Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Montefiore Medical Center-Wakefield Campus
mi
from
Bronx, NY
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Montefiore Medical Center-Wakefield Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Summa Akron City Hospital/Cooper Cancer Center
mi
from
Akron, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Columbus NCI Community Oncology Research Program
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Columbus NCI Community Oncology Research Program
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Mount Carmel Health Center West
mi
from
Columbus, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Luke's University Hospital-Bethlehem Campus
mi
from
Bethlehem, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Luke's University Hospital-Bethlehem Campus
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
University of Pittsburgh Cancer Institute (UPCI)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Geisinger Wyoming Valley/Henry Cancer Center
mi
from
Wilkes-Barre, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Geisinger Wyoming Valley/Henry Cancer Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Lankenau Medical Center
mi
from
Wynnewood, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Main Line Health NCORP
mi
from
Wynnewood, PA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Main Line Health NCORP
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
West Virginia University Charleston
mi
from
Charleston, WV
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Nicholas Hospital
mi
from
Sheboygan, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Instituto Nacional de Enfermedades Neoplasicas
mi
from
Lima,
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Instituto Nacional de Enfermedades Neoplasicas
mi
from
Lima,
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Michigan Cancer Research Consortium NCORP
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Beaumont Hospital-Dearborn
mi
from
Dearborn, MI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases
Status: Enrolling
Updated:  8/18/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients With 1-4 Brain Metastases
Status: Enrolling
Updated: 8/18/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated:  8/18/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated: 8/18/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
Treatment Decisions and Breast Cancer: Psychosocial Outcomes
Status: Enrolling
Updated:  9/15/2016
Kelsey Seybold
mi
from
Houston, TX
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
Treatment Decisions and Breast Cancer: Psychosocial Outcomes
Status: Enrolling
Updated: 9/15/2016
Kelsey Seybold
mi
from
Houston, TX
Click here to add this to my saved trials
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
Treatment Decisions and Breast Cancer: Psychosocial Outcomes
Status: Enrolling
Updated:  9/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
Treatment Decisions and Breast Cancer: Psychosocial Outcomes
Status: Enrolling
Updated: 9/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Aurora BayCare Medical Center
mi
from
Green Bay, WI
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Aurora BayCare Medical Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Saint Lukes Hospital
mi
from
Kansas City, MO
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Saint Lukes Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated:  10/21/2016
Washington University
mi
from
Saint Louis, MO
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Phase 2 Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma
Status: Enrolling
Updated: 10/21/2016
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects
A Phase I Study to Evaluate the Pharmacokinetic and Safety Profile of AZD9496 Following Single Dose Administration of Different Forms and Formulations in Healthy Subjects
Status: Enrolling
Updated:  11/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects
A Phase I Study to Evaluate the Pharmacokinetic and Safety Profile of AZD9496 Following Single Dose Administration of Different Forms and Formulations in Healthy Subjects
Status: Enrolling
Updated: 11/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
Status: Enrolling
Updated:  11/14/2016
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
Status: Enrolling
Updated: 11/14/2016
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Proton Radiation for Resectable Carcinoma of the Pancreas
A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
Status: Enrolling
Updated:  11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Proton Radiation for Resectable Carcinoma of the Pancreas
A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas
Status: Enrolling
Updated: 11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 11/17/2016
University of Florida Proton Therapy Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  11/17/2016
Provision Proton Therapy Center
mi
from
Knoxville, TN
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 11/17/2016
Provision Proton Therapy Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated:  11/17/2016
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated: 11/17/2016
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated:  11/17/2016
University of New Mexico
mi
from
Albuquerque, NM
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated: 11/17/2016
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated:  11/17/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery
Genome-Wide Methylation and Gene Re-expression Analysis of Resectable Lung Tumor Tissue Pairs Obtained Pre- and Post-Treatment With 5-Azacytidine and Entinostat
Status: Enrolling
Updated: 11/17/2016
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/17/2016
Mayo Clinic
mi
from
Scottsdale, AZ
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/17/2016
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/17/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA Seq, and Exome Sequencing of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/17/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Phase I Study of Intravenous Artesunate for Solid Tumors
A Phase I Study of Intravenous Artesunate in Patients With Solid Tumors
Status: Enrolling
Updated:  11/17/2016
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington,
Phase I Study of Intravenous Artesunate for Solid Tumors
A Phase I Study of Intravenous Artesunate in Patients With Solid Tumors
Status: Enrolling
Updated: 11/17/2016
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated:  11/21/2016
Massachusetts General Hospital
mi
from
Boston, MA
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated: 11/21/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated:  11/21/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated: 11/21/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated:  11/21/2016
Children's Hospital Boston
mi
from
Boston, MA
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated: 11/21/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated:  11/21/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
Status: Enrolling
Updated: 11/21/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer
A Pilot, Single Arm, Study of the Safety and Feasibility of Single-Fraction Intraoperative Radiation Treatment (IORT) With CT-On-Rails-Guided HDR Brachytherapy for the Treatment of Early-Stage Breast Cancer
Status: Enrolling
Updated:  11/21/2016
University of Virginia Health System
mi
from
Charlottesville, VA
IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer
A Pilot, Single Arm, Study of the Safety and Feasibility of Single-Fraction Intraoperative Radiation Treatment (IORT) With CT-On-Rails-Guided HDR Brachytherapy for the Treatment of Early-Stage Breast Cancer
Status: Enrolling
Updated: 11/21/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects With BRAF V600 Mutation Positive Tumors
Status: Enrolling
Updated:  11/21/2016
GSK Investigational Site
mi
from
Lebanon, NH
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects With BRAF V600 Mutation Positive Tumors
Status: Enrolling
Updated: 11/21/2016
GSK Investigational Site
mi
from
Lebanon, NH
Click here to add this to my saved trials
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects With BRAF V600 Mutation Positive Tumors
Status: Enrolling
Updated:  11/21/2016
GSK Investigational Site
mi
from
Barcelona,
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects With BRAF V600 Mutation Positive Tumors
Status: Enrolling
Updated: 11/21/2016
GSK Investigational Site
mi
from
Barcelona,
Click here to add this to my saved trials
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
A Phase II Study of Erlotinib (Tarceva®) in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy
Status: Enrolling
Updated:  11/22/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
A Phase II Study of Erlotinib (Tarceva®) in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy
Status: Enrolling
Updated: 11/22/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Rural Women Connecting for Better Health
Group Phone-Based Weight Control for Rural Breast Cancer Survivors
Status: Enrolling
Updated:  11/22/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Rural Women Connecting for Better Health
Group Phone-Based Weight Control for Rural Breast Cancer Survivors
Status: Enrolling
Updated: 11/22/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced Ultrasound (US) in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
LCCC 1219: A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced US in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
Status: Enrolling
Updated:  11/22/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced Ultrasound (US) in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
LCCC 1219: A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced US in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
Status: Enrolling
Updated: 11/22/2016
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials